[Cardiac toxicity of antimalarials]
- PMID: 7746132
[Cardiac toxicity of antimalarials]
Similar articles
-
Epinephrine requirement based on the reported ingested dose in chloroquine poisoning: usefulness and limitations of dose-effect modelling.Clin Toxicol (Phila). 2011 Mar;49(3):193-4. doi: 10.3109/15563650.2011.563746. Clin Toxicol (Phila). 2011. PMID: 21495891 No abstract available.
-
Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices.Life Sci. 2007 Mar 13;80(14):1327-34. doi: 10.1016/j.lfs.2006.12.019. Epub 2007 Jan 11. Life Sci. 2007. PMID: 17303179
-
Toxicology and pharmacokinetics of piperaquine in mice.Toxicology. 2008 Jul 10;249(1):55-61. doi: 10.1016/j.tox.2008.04.004. Epub 2008 Apr 16. Toxicology. 2008. PMID: 18502018
-
Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.Fundam Clin Pharmacol. 2009 Aug;23(4):387-409. doi: 10.1111/j.1472-8206.2009.00709.x. Fundam Clin Pharmacol. 2009. PMID: 19709319 Review.
-
Toxicity of antimalarial drugs in rheumatoid arthritis.Agents Actions Suppl. 1993;44:151-7. Agents Actions Suppl. 1993. PMID: 8372725 Review.
Cited by
-
Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?BMC Public Health. 2002 Mar 25;2:6. doi: 10.1186/1471-2458-2-6. BMC Public Health. 2002. PMID: 11914150 Free PMC article.